Related Experiment Video
Updated: Jun 17, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018
[Benign prostatic hyperplasia (BPH) : Surgical therapy options]
1Urologische Klinik und Poliklinik, Klinikum Grosshadern, Ludwig-Maximilians-Universität München, 81377, München, Deutschland. oreich@med.uni-muenchen.de
Abstract:
The surgical treatment options available today for benign prostatic hyperplasia (BPH) can take various forms and often follow a course of pharmacological therapy. In addition to conventional transurethral resection of the prostate (TURP) and its modifications (bipolar resection), which has represented the standard therapeutic option for decades, the focus of research and clinical application has shifted to alternative so-called "minimally invasive" instrumental techniques, such as transurethral microwave therapy (TUMT) and, particularly more recently, to the different laser-assisted techniques. By reviewing the current literature, preferably from randomized controlled trials, critical appraisals of the individual procedures are made.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Urinary Tract Calculi III: Medical Management
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
